Encompass Health
$112.45
▲ +1.24%
+$1.38
NYSE · Healthcare · Medical Care Facilities
· price updated 9h ago
EHC · NYSE · Healthcare · Medical Care Facilities · price updated 9h ago
$112.45
▲ +1.24% · +$1.38 today
AI research · $112.45
Operating record
Capital structure
Valuation
Forward P/E
Price against expected earnings
Favorable · 13% below Sector avg · favorable
18.17x
Price / sales
Value assigned to each sales dollar
Strong · Under 3x annual sales
1.82x
Price / FCF
Price against free cash generation
Reasonable · Between 20x and 35x free cash flow
23.73x
EV / EBITDA
Operating value including debt
Strong · Under 12x operating cash earnings
9.62x
Quality
ROIC
Return earned on invested capital
Reasonable · An 8% to 15% return on capital
14.4%
ROE
Profit generated from shareholder equity
Favorable · Exceptional vs sector peers
25.2%
Debt / equity
Balance-sheet leverage
Middle ground · Roughly in line with sector
0.83x
Current ratio
Short-term assets against liabilities
Reasonable · Assets still cover near-term liabilities
1.17x
Selected financial data sourced from StockAnalysis and refreshed weekly. Figures may be delayed and are for research context, not investment advice.
| company | mkt cap | P/E | rev growth | score |
|---|---|---|---|---|
| $11.02B | 18.5 | +10.1% | 71 | |
| $10.69B | 18.4 | +23.5% | 78 | |
| $4.88B | 20.3 | +10.3% | 77 | |
| $31.49B | 32.9 | +15.5% | 77 | |
| $1.08T | 41.4 | +47.4% | 76 |
US stock research
Encompass Health tracked in the US core universe. EHC was +1.2% in the latest available session at $112.45. Its reported market value was $11.02B with a trailing P/E of 18.5. Latest reported revenue was $6.07B, changing +10.1% year over year, with $609.20M in net income.
Market snapshot updated Aug 3, 2026, 7:59 PM UTC.